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Cloning, Expression, and Sequence Analysis of Camelysin, a Zinc 
Metalloprotease from Bacillus anthracis and B. cereus 
Andrew Ross Myers 
ABSTRACT 
 Bacillus anthracis and B. cereus are well known etiological agents, which 
cause disease in healthy and immunocompromised individuals.  Considering the 
abundance and lethality of these organisms it is imperative that research is 
performed to identify and analyze new factors that may contribute to their 
pathogenicity.  Camelysin is a membrane bound, zinc metalloprotease isolated 
from B. cereus.  Assays performed on purified camelysin demonstrate that the 
protease exhibits fibrinolytic, collagenolytic, and actin degradation activity, any of 
which can contribute to the organism’s ability to invade host tissues and cause 
damage.  Considering the putative role of camelysin in pathogenicity, it would be 
beneficial to study the effects of camelysin in tissue cultures or animal models.  
The goal of this study focused on the cloning and expression of camelysin from 
B. cereus and its homolog in B. anthracis.  Expression of a fusion tagged protein 
may assist in the purification of camelysin as well as overcoming the native 
protein’s extreme insolubility.  Primers were designed to amplify the camelysin 
gene from B. cereus for cloning into the prokaryotic pBAD TOPO® TA, 
pET100/D-TOPO®, and the eukaryotic pcDNA3.1/V5-His© TOPO® TA expression 
viii 
vectors.  Primers were also designed to amplify the gene from B. anthracis for 
cloning into the pBAD TOPO® TA vector.  The recombinant clones were induced 
and successful expression of the protein was confirmed by performing SDS-
PAGE, Western blotting, and an azocasein protease assay.  The recombinant 
proteins exhibited casein degradation activity which is observed with purified 
camelysin from B. cereus.  This study successfully demonstrated the presence of 
the camelysin protein in B. anthracis.  Furthermore, the recombinant clones 
obtained will be useful for purification and analysis of camelysin and delineation 
of its role in the pathogenicity of B. cereus and B. anthracis. 
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INTRODUCTION 
Bacillus anthracis and Bacillus cereus are known pathogens, which have 
various effects on the human body.  Both healthy and immunocompromised 
individuals can become infected with these organisms and both B. anthracis and 
B. cereus contain many similar virulence factors (20).  There have been 
numerous studies performed which have identified the main factors of 
pathogenicity in these organisms, and most have resulted in therapeutic 
treatments against these commonly known factors.  Most of these treatments 
however are ineffective by the time physicians identify the presence of these 
pathogens, due to the fact that some are often considered clinical laboratory 
contaminants (10, 31).  However, to this date there have been no recent studies 
aimed at identifying any new pathogenicity factors in these organisms that could 
be of therapeutic value.  This study focused on the identification and expression 
of a zinc metalloprotease, camelysin, in B. cereus ATCC 14579 and B. anthracis, 
which share many common factors of pathogenicity (15).   
B. anthracis, B. cereus, and B. thuringiensis are all Gram positive, rod 
shaped, spore forming, facultative aerobes, and most have plasmids that encode 
toxins.  They are commonly found in the soil, and all are classified as group I 
bacilli, which contains most of the bacilli that cause infection, and all three 
organisms are indistinguishable from each other based on 16srRNA analysis (10, 
 2 
20, 31, 36, 38).  All three have plasmids, some encoding toxins like the pXO1 
found in B. anthracis, and pBc10987 of B. cereus which is homologous to the 
pXO1 plasmid, but lacks the genes producing the lethal and edema toxins (38).  
The spore forms of these organisms are resistant to heat, gamma radiation, and 
even hospital based antimicrobial handwashes and disinfectants (22, 10).  B. 
anthracis and B. cereus mainly affect humans, while B. thuringiensis affects 
insects.  Due to this fact, our study concentrated on the screening and 
identification of the camelysin gene from B. anthracis and B. cereus ATCC 
14579.   
The ten main infections resulting from B. cereus include local infections of 
burns or trauma, septicemia and bacteremia, meningitis, respiratory infections, 
endocarditis, urinary tract infections, skin infection, eye infections, osteomyelitis, 
and food poisoning (10, 22, 23).  B. cereus mainly causes gastrointestinal 
distress resulting from contaminated food, but is also know to cause non-
gastrointestinal disease in immunocompromised people such as individuals with 
AIDS, newborns, people recovering from surgery, and IV drug users (10, 22).  
The main drug users affected by B. cereus infections are those who are heroin 
addicts, not just because the needles may become contaminated with 
pathogens, but due to the fact that B. cereus often is found as a contaminate of 
heroin (22).   
The most prevalent infection associated with B. cereus is a result of 
ingestion of contaminated foods such as rice, pasta, and dairy products (22).  
There are two types of food poisoning that affect humans: the emetic food 
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poisoning, and the diarrheal food poisoning.  The diarrheal food poisoning is 
caused by the HBL and NHE enterotoxin complexes, which induce the following 
symptoms: abdominal pain, cramps, rarely a fever, occasional vomiting, and 
diarrhea which last for 1 to 2 days (10, 22).  Vomiting usually starts 10 hours after 
ingestion since the toxin can be preformed (10).  This type of food poisoning is 
similar to that of Clostridium perfringens, which may lead to misdiagnosis of B. 
cereus infections.   
 The emetic food poisoning is caused by the heat resistant toxin, cereulide, 
which is a type of hemolysin (22).  Symptoms of the emetic food poisoning 
appear similar to the food poisoning of Staphylococcus aureus and include 
nausea, vomiting, and occasional diarrhea (10, 22).  Since the toxin is always 
preformed it can cause symptoms in as little as 15 minutes.   
 Since the gastrointestinal infections are the most common result of a B. 
cereus infection, physicians tend to overlook cases in which B. cereus is the 
source of the infection.  This stems from the fact that B. cereus infections are not 
routinely screened for in some countries because they are not listed as 
reportable illnesses (22).  This is a strange fact, especially since B. cereus is 
commonly found in the hospital environment, sometimes causing nosocomial 
infections (2, 5, 19, 27).  One patient undergoing neurosurgery developed 
meningitis due to linens contaminated with B. cereus (22).  Another example 
included the misdiagnosis of B. cereus infections in two people in Louisiana (31).  
The first patient exhibited symptoms of pneumonia 5 days before admission into 
the hospital, where he was diagnosed with a lung tumor and died that same day.  
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The second patient was admitted to the hospital after 3 days of symptoms, was 
diagnosed with tuberculosis and died 3 days later.  Both were given antibiotics 
that should have treated the infection, however they received them too late, 
sepsis overtook their bodies and was later determined to be the cause of death in 
both individuals (31).  This is why it is important that studies be continued on B. 
cereus that focus on identification of new virulence factors and faster methods to 
detect the pathogen.   
 B. anthracis mainly infects the respiratory tract of individuals although rare 
cases of gastrointestinal infections have been reported.  The main factors 
contributing to the virulence of B. anthracis include a toxin complex, the ability of 
the organism to form spores that are easily aerosolized, as well as a capsule that 
is present in its virulent form which may help the organism evade the immune 
system (29, 34, 38).  B. anthracis has two large plasmids (pXO1 and pXO2) that 
encodes for proteins that must be present for the organism to be fully virulent (1).  
pXO1 is the plasmid that contains the genes for the toxin complex.  The toxin 
complex is made up of the edema factor, lethal factor, and protective antigen 
encoded by cya, lef, and pagA respectively (38).  The protective antigen is a 
major component of the cell free vaccines on the market that are for human use 
(1).  pXO1 is 182 kb and the pathogenicity island which contains cya, lef, and 
pagA, is only 44.8 kb in size, the island is surrounded by two IS1627 elements 
thus suggesting that it may be mobile (38). Plasmid pXO2 contains the gene that 
encodes for the Poly-d-glutamic acid capsule that aids in antiphagocytic activity 
(34).  Although treatments and a vaccine are available for this organism, they are 
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not as effective as treatments for simple infections such as gastroenteritis.  More 
work needs to be done to identify new virulence factors, and this study will 
encompass the use of B. anthracis, since sequence information has identified a 
putative camelysin gene in its genome.   
 Camelysin is a membrane bound neutral zinc metalloprotease with a 
molecular mass of approximately 19 kDa and is found in an uncharacterized 
strain of B. cereus while in the logarithmic phase of growth (15, 16, 24).  The 
camelysin protein also known as casein cleaving metalloprotease, has been 
studied and characterized within the last ten years.  Recent studies have outlined 
camelysin as a possible pathogenicity factor as it has fibrinolytic, collagenolytic, 
and actin degradation activity (15).  These activities may contribute to the ability 
of B. cereus or any other organisms that contain the camelysin protein to invade 
host tissues and cause damage. 
 Proteases are divided into two major groups; those that cleave peptide 
chains at the ends, and those that cleave the peptide chains towards the middle, 
these are exopeptidases and endopeptidases respectively (37).  Next the 
proteases are further classified by the residues that are at their active site into 
serine, aspartic, cysteine, and metallo-proteases.  Metalloproteases usually 
require divalent metal ions for activity (37).  Zinc peptidases consist of 30 families 
and are divided into 5 major clans (25, 37).  The HEXXH motif is typically found 
in zinc metalloproteases at the zinc-binding region and is usually contained in an 
alpha helical region of the protein (26). 
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 The first studies on camelysin were focused on establishing a number of 
general characteristics.  The molecular weight was determined first by SDS-
PAGE and then by mass spectrometry.  SDS-PAGE performed (under reducing 
conditions, beta-mercaptoethanol) showed two bands, one at 58 kDa and the 
other at 64 kDa (13).  Under non-reducing conditions the protease exhibits self- 
aggregation on the top part of the gel (13, 15).  Even after boiling for several 
minutes with SDS, the protease was able to form aggregates.  This self- 
aggregation is possibly caused by the oligomerization of the protease, which may 
explain the different molecular mass obtained by mass spectrometry (indicated 
MW= 19 kDa) as compared to SDS-PAGE.   
 Purified camelysin is shown to have the characteristics of an 
endopeptidase, which is a protease that cleaves towards the middle of the 
proteins, and may be involved in several pathogenicity pathways (37).  
Camelysin is able to cleave collagen type I, the most abundant collagen type that 
is found in skin, bones, and tendons (15).  The protease cleaved the heterotrimer 
(collagen) in a similar manner to other bacterial collagenases (15).  Other studies 
have found unidentified collagenases present during the log phase of growth on 
the outer membrane of B. cereus that may be responsible for binding to host 
cells.  There is another hypothetical collagenase that may play a role in the 
degradation of collagen, which protects the lens capsule of the eye (2).  B. 
cereus is known to cause ocular infections (endophthalmitis) by interacting with 
other pathogenicity factors which may play a role in these infections (15).   
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 Camelysin has also been shown to activate plasminogen to plasmin and 
also destroys ?2-antiplasmin.  ?2-antiplasmin keeps plasmin from degrading fibrin 
clots by forming a complex with it, and  inactivating it (15).  Cleavage of actin is 
also catalyzed by camelysin, and this could be a possible mechanism associated 
with the diarrheal effects of the organism (15). 
Other zinc metalloproteases of different organisms have been shown to 
cause damage to cellular structures (7).  One example is from Vibrio vulnificus, 
which has a protease that destroys collagen type IV, which results in the 
breakdown and collapse of capillary vessels (32).  The destruction is due to the 
fact that the basal membranes surrounding the capillaries are made of collagen 
and laminin and once these are digested the capillaries have no structure holding 
them together, resulting in collapse and hemorrhaging.  Venom from certain 
snakes may also contain zinc metalloproteases that act in the same fashion.  In 
multiple sclerosis patients, zinc dependant matrix metalloproteases cause the 
breakdown of connective tissue; under normal circumstances the collagen is 
resistant to proteases because of its supercoiled triple helices and this is not the 
case in MS patients (4).  In some people with cancer, the concentration of matrix 
metalloproteases is higher in patients who are sick as compared to those who 
are healthy.  In certain cancers the concentration of matrix metalloproteases is 
increased during the beginning stages of metastasis and matrix metalloprotease 
inhibitors are used to prevent metastasis from occurring (11, 40).  Zinc 
metalloproteases do not always cause damage: some actually are involved in the 
formation of bone tissue and a variety of other useful biological materials (18). 
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   When it came to the purification of camelysin, solubilization of the active 
protein was difficult.  Several non-ionic detergents were experimented with 
(Triton X-100, Brij 35, and Octylthioglucoside) and none were able to solubilize 
the protein in its active form (13).  Later, Fricke et al. (13, 15) experimented with 
Sulfobetain SB-12 and it successfully solubilized the protein in its active form.  
This detergent was used to form a stable complex with the protein so it remained 
stable outside of the cell membrane and it also protected the hydrophobic ends 
from hydrophilic environments.  Protease activity remained for several days 
without the addition of phospholipids when stored at 4° C.  The mechanism of the 
protein removal involved the detergent replacing the phospholipids molecules in 
the cell membrane when the detergent was in high concentration.  Decreasing 
the detergent concentration resulted in increased activity of the protease, which 
shows that the absence of the phospholipids did not have an inactivating effect.   
Due to the high hydrophobicity of the protein, purification of the 
solubilizate is difficult.  Mixed micelles form during purification between 
phospholipids and different membrane proteins as well as between different 
membrane proteins and the detergent (15).  The detergent is also known to 
cause problems column matrix, thus it must be removed or diluted before 
addition to the columns (13).  Conventional techniques for purification such as 
hydrophobic interaction chromatography (Butyl sepharose and Phenyl 
sepharose), chromatofocusing (PBE 94), and most forms of ion exchange 
chromatography cannot be used due to the hydrophobicity of the aggregated 
protease (15).  However, in one study, ion exchange chromatography using EMD 
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TMAE Fractogel resulted in the partial purification of the protein (13).  The only 
way to elute the protein from the column matrix involved the use of high 
concentrations of isopropanol.  Subsequent studies showed that the polar 
solvents caused denaturation and inactivation of camelysin.  In the latest study 
the purified protein was obtained using a Butyl Toyopearl column without any 
major loss in enzyme activity, and the usage of polar solvents was omitted (15). 
In Grass et al., 2004, the molecular characteristics of the camelysin gene 
and protein were studied.  Inverse PCR allowed the cloning of the gene and a 
gene knockout demonstrated that it was indeed camelysin that caused the 
protease activity in B. cereus (16).  The studies also revealed that camelysin 
lacked the HEXXH motif commonly found in zinc metalloproteases and it had no 
conserved domains like most proteins, thus making it very unique.  Our study will 
focus on the identification of the secondary structure of camelysin using the 
sequence information obtained from Dr. Grass and will be used to clone the gene 
into various expression vectors.  Once a suitable vector system is identified, Dr. 
Grass will perform mutational studies to identify this rare zinc binding motif.  This 
study will also identify whether or not the camelysin gene is present in B. 
anthracis and if so, further experiments will allow us to look at its possible role in 
the pathogenicity of these organisms.   
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MATERIALS AND METHODS 
 
Chemicals and Reagents  
 The Wizard® Genomic DNA Purification Kit, restriction enzymes, and the 
PCR reagents were purchased from Promega Inc. (Madison, WI) and were used 
according to the manufacturer’s protocols.  PCR primers were synthesized by 
Operon Biotechnologies (Huntsville, AL).  PfuTurbo® DNA polymerase was 
purchased from Stratagene Inc. (La Jolla, CA).  The expression vectors pBAD 
TOPO® TA, pcDNA3.1/V5-His© TOPO® TA, and pET100/D-TOPO® were obtained 
from Invitrogen Life Technologies (Carlsbad, CA).  All other chemicals and 
reagents were purchased from Fisher Scientific (Pittsburg, PA), Sigma-Aldrich 
Co. (St. Louis, MO), or Bio-Rad Laboratories (Hercules, CA) unless otherwise 
noted.   
 
Bioinformatics Analysis 
 The DNA sequence for the camelysin gene in B. anthracis Ames Strain 
and B. cereus ATCC 14579 were obtained from the National Center for 
Biotechnology Information (NCBI) Entrez server.  Multiple sequence analysis was 
performed using the GAP alignment tool from the GCG Wisconsin Package® 
software (Accelrys Inc., San Diego, CA) using nucleotide, amino acid, and 
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secondary structure sequences.  Predictions of the signal peptides were obtained 
from the SignalP 3.0 server (3).   Secondary structure predictions were obtained 
using PSIPRED Protein Structure Prediction Server (21, 28).   
 
Bacterial Strains, Eukaryotic Cells, and Growth Conditions 
 B. cereus ATCC 14579 was obtained from Dr. Daniel Lim (University of 
South Florida Biology Department, Tampa, FL) and cultured at 37ºC in brain 
heart infusion broth (Difco, Detroit, MI).  HeLa cells (CCL-2) were obtained from 
ATCC (Manassas, VA) for eukaryotic expression and were cultured in EMEM 
supplemented with 10% FBS at 37ºC in 5% CO2.  Chemically competent 
Escherichia coli TOP10 cells were purchased from Invitrogen and used for the 
cloning of all constructs, and the expression of BAcalY-pBAD and BCcalY-pBAD.  
E. coli BL21 Star™ (DE3)pLysS cells were purchased and used for the cloning 
and expression of BCcalY-pET100D.  Luria-Bertani (LB) broth (Difco, Detroit, MI) 
supplemented with 100?g/mL ampicillin (LB-AMP) was used for culturing and 
expression of camelysin in the TOP10 and BL21 transformants.  Conditions for 
expressing the pBAD and pET constructs  included growth in LB-AMP broth at 
30ºC, while conditions for mammalian cells remained the same except for the 
absence of 10% FBS for four and a half hours during the transfection.   
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Genomic DNA Isolation 
 Genomic DNA was isolated using the Promega Wizard® genomic DNA 
purification kit.  A 10mL overnight culture was grown in LB broth in a shaking 
incubator at 37ºC.  1mL of the culture was removed and centrifuged at 16,000 X 
g for 2 minutes.  The cell pellet was resuspended in 480?L of 50mM EDTA and 
60?L of a 10mg/mL solution of lysozyme, which was incubated at 37ºC for 45 
minutes.  The sample was centrifuged at 16,000 X g for 2 minutes and 600?L of 
Nuclei Lysis Solution was added to resuspend the cells.  To continue the cell 
lysis, the sample was incubated at 80ºC for 5 minutes.  The samples were then 
incubated at 37ºC for 45 minutes with 3?L of RNase Solution to remove any RNA 
present in the samples.  After cooling to room temperature, 200?L of Protein 
Precipitation Solution was added to the sample, which was then placed on ice for 
5 minutes to aid in the precipitation.  The sample was then centrifuged at 16,000 
X g for 3 minutes and the supernatant containing the DNA was transferred to a 
fresh tube that contained 600?L of isopropanol to precipitate the DNA.  The DNA 
was pelleted by centrifugation at 16,000 X g for 2 minutes.  Next, the supernatant 
was removed and 600?L of 70% ethanol was added to rinse the pellet.  The 
sample containing the purified DNA was then centrifuged for another 2 minutes 
at 16,000 x g.  The supernatant was removed and the pellet was allowed to air 
dry, after which 100?L DNA Rehydration Solution was added.  The resulting DNA 
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was analyzed on a 1% agarose gel for quality control, and the concentration and 
purity of the DNA was determined using the SmartSpec Plus Spectrophotometer 
(Bio-Rad).   
 
PCR Amplification 
PCR was performed on the genomic DNA for identification and cloning of 
the camelysin gene.  The PCR products for the pBAD TOPO® TA vector were 
amplified using the Expand Long Template PCR System (Roche Applied 
Science, Indianapolis, IN), in which each reaction contained 3 units of Taq and 
Tgo polymerases, 200?M of dNTP’s, 250ng of genomic DNA, 50?L of Buffer 3, 
and 0.4?M of each primer were used (Table 2).  PCR products for the pcDNA3.1 
TOPO® TA vector were amplified using the PCR Mastermix (Promega) which 
contains a Taq polymerase with terminal transferase activity that adds adenosine 
residues onto the amplification product.  For this amplification 0.625 units of Taq 
polymerase, 200?M of dNTP’s, 137ng of genomic DNA, and 0.4?M of each 
primer were used.  The PCR products for the pET100/D-TOPO® were amplified 
using the PfuTurbo® DNA polymerase (Stratagene), which resulted in blunt 
ended PCR products.  For this amplification, 2.5 units of PfuTurbo® DNA 
polymerase, 200?M of dNTP’s, 100ng of genomic DNA, 0.4?M of each primer 
(Table 2), and 1x PCR reaction buffer (Stratagene) were used.  The conditions of 
each PCR reaction are described in Table 1. 
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Table 1. Conditions used for PCR Amplification of camelysin from B. anthracis 
and B. cereus 
 
Primer Pair PCR Conditions 
B. anthracis DNA: pBAD calY forward, 
pBAD calY reverse 
95ºC for 2 minutes (Initial Denaturation) 
 
95ºC for 30 seconds (Denaturation) 
55ºC for 30 seconds (Annealing) 
68ºC for 1 minute (Extension) 
Repeated 25 times 
 
68ºC for 7 minutes (Final Extension) 
B. cereus DNA: pBAD calY forward, 
pBAD calY reverse 
95ºC for 2 minutes (Initial Denaturation) 
 
95ºC for 30 seconds (Denaturation) 
55ºC for 30 seconds (Annealing) 
68ºC for 1 minute (Extension) 
Repeated 25 times 
 
68ºC for 7 minutes (Final Extension) 
B. cereus DNA: pcDNA calY forward, 
pcDNA calY reverse 
96ºC for 2 minutes (Initial Denaturation) 
 
96ºC for 30 seconds (Denaturation) 
56ºC for 30 seconds (Annealing) 
72ºC for 1 minute (Extension) 
Repeated 26 times 
 
72ºC for 15 minutes (Final Extension) 
B. cereus DNA: pET calY forward, pET 
calY reverse 
95ºC for 2 minutes (Initial Denaturation) 
 
95ºC for 30 seconds (Denaturation) 
53ºC for 30 seconds (Annealing) 
72ºC for 1 minute (Extension) 
Repeated 26 times 
 
72ºC for 10 minutes (Final Extension) 
 
   
Ligation into Expression Vectors and Cloning 
The PCR products amplified using the Promega Taq polymerase, and the 
Roche Tgo and Taq polymerases were ligated into the pcDNA3.1 TOPO® TA and 
pBAD TOPO® TA vectors respectively.  Briefly, 2?L of the PCR products were 
added to 2?L of water, and 1?L of the appropriate linearized vector.  The ligation 
reaction was incubated at room temperature for 5 minutes and placed on ice.  
Transformation was completed by taking 2?L of the ligation products and adding 
 15
them to E. coli TOP10 cells, which were incubated on ice for 15 minutes.  Next, 
the cells were heat shocked for 30 seconds in a 42ºC water bath and 250?L of 
S.O.C. medium (Invitrogen) was added, followed by incubation at 37ºC for one 
hour in a shaking incubator.  LB-AMP plates were inoculated with 20?L and 40?L 
volumes of each transformation reaction and incubated overnight at 37ºC.  
Individual colonies were removed and screened for BAcalY-pBAD, BCcalY-
pBAD, or BCcalY-pcDNA using PCR amplification with primers (Table 2) specific 
for either the native plasmid or the inserted camelysin gene.  Restriction enzyme 
digestion of BCcalY-pcDNA was also carried out using 25 units of BstX I per 1?g 
of plasmid DNA and results were observed on an agarose gel.   
The PCR products amplified using the PfuTurbo® polymerase were ligated 
into the pET100/D-TOPO® vector.  The PCR product was diluted 1:25 in 
nuclease free water and 3?L of this product was added to 1?L of dilute salt 
solution, 1?L of water, and 1?L of linearized vector.  Both the ligation reaction 
and transformation into E. coli TOP10 cells were carried out according to the 
protocols listed above.  Two different sets of PCR primers (Table 2) were used to 
identify colonies containing BCcalY-pET100D.  Sequencing analysis of each 
recombinant plasmid was performed at SeqWright DNA Technology Services 
(Houston, TX) using a forward primer (Table 2) specific for the vector, and a 
reverse primer specific for the inserted camelysin gene.   
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Plasmid Isolation and Analysis of Recombinant Clones 
Plasmid isolation was performed using the FastPlasmid™ Mini kit from 
Eppendorf (Westbury, NY).  E. coli TOP10 cells containing the recombinant 
plasmids were grown in LB-AMP for 15 hours in a shaking incubator at 37ºC to 
an OD600 of 2.4.  1.5?L of each culture was removed and were centrifuged at 
15,000 x g for 1 minute.  The supernatant was removed and 400?L of the lysis 
solution, containing RNase A and lysozyme was added to the pellet.  The pellet 
was resuspended by vortexing on high speed for approximately 30 seconds, 
followed by a 3 minute incubation at room temperature.  The lysate was then 
transferred to a spin column assembly which was then centrifuged for 1 minute at 
15,000 x g.  The remaining plasmid DNA contained in the spin column matrix 
was washed with 400?L of diluted wash buffer and centrifuged for another 
minute.  Filtrate remaining in the bottom of tube was removed and the spin 
column assembly was centrifuged for 1 minute to remove any excess 
isopropanol that was introduced with the washing buffer.  Next, the spin column 
was placed into a collection tube and the DNA was eluted by adding 50?L of 
buffer containing 10mM Tris-HCl / 0.1mM EDTA, pH 8.5 followed by 
centrifugation at 15,000 x g for 1 minute.  Plasmid DNA used for transfections 
was prepared using the Qiagen Plasmid Midi kit according to the manufacturer’s 
protocol.   
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Transfection and Expression of BCcalY-pcDNA in HeLa cells 
 Transient transfections were performed using the following constructs; 
BCcalY-pcDNA (pcDNA3.1 with the camelysin gene), calY-pcDNA(-) (pcDNA3.1 
without any insert), and pcDNA3.1/V5-His-TOPO/lacZ© (pcDNA3.1 that 
contained the ß-galactosidase control).  A negative control designated HeLa1 
(HeLa cells with no vector) underwent the same treatments as transfected cells 
to make sure the lipid had no toxic effects on the cells.  Prior to transfection the 
HeLa cells were plated in a 12-well plate at a cell density of approximately 7.8 x 
104 cells per well and were incubated overnight at 37ºC in 5% CO2 until mostly 
confluent (~90-100%).  The following day, plasmid DNA obtained from the Midi 
preps was diluted at a ratio of 1.6?g of DNA per 100?L of Opti-MEM (Invitrogen) 
and the Lipofectamine™ 2000 (Invitrogen) reagent was diluted at a ratio of 4?L 
lipid per 100?L of Opti-MEM according to the manufacturer’s protocol.  The 
diluted DNA/Lipid mixtures were combined and incubated at room temperature 
for 20 minutes. The growth medium was then removed and the entire plate was 
washed with PBS, then 1mL of EMEM without 10% FBS was added to each well.  
Next, 200?L DNA/Lipid mixture was added to each well and the plates were 
incubated for 4.5 hours at 37ºC in 5% CO2.  The growth media then was 
removed and replaced with fresh EMEM containing 10% FBS and the 
transfection reaction was allowed to continue for 24 hours.  The next day, the 
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cells were detached from their respective plates using sterile cell scrapers and 
transferred to microcentrifuge tubes.  After spinning down the cells, both the 
pellet and supernatant were frozen at -20ºC for western blotting analysis, SDS-
PAGE, and an azocasein enzyme assay.   
 
Expression of BAcalY-pBAD and BCcalY-pBAD and in E. coli TOP10 Cells 
 The pBAD vector in TOP10 cells, containing either the camelysin gene 
from B. anthracis (BAcalY-pBAD) or from B. cereus (BCcalY-pBAD) were used to 
express the camelysin protease (35). One other construct designated calY-
pBAD(-) (pBAD with no insert) was also induced during the expression 
experiment, along with TOP10 cells containing no vector.  All cultures were 
grown in 10mL of LB-AMP overnight at 37ºC in a shaking incubator.  7mL of the 
cultures containing BAcalY-pBAD and BCcalY-pBAD were added to 70mL of LB-
AMP, and 2mL of cultures containing calY-pBAD(-) and TOP10 cells were added 
to 20mL of LB-AMP.  All cultures were grown for approximately 2 hours to an 
OD600 of ~0.75 and then induced with various concentrations of arabinose before 
a 4 hour incubation at 30ºC.  At the end of the induction, 5?L of each sample was 
removed to obtain their respective OD600.  Finally, the samples were centrifuged 
and the supernatant was transferred to a fresh tube, then both the supernatant 
and pellet from each culture were frozen at -20ºC for future analysis.  
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Expression of BCcalY-pET100D in E. coli BL21 Star™ (DE3)pLysS Cells 
  The pET vector containing the camelysin gene from B. cereus (BCcalY-
pET100D) was obtained from the TOP10 cells using the plasmid miniprep kit as 
mentioned above.  BL21 Star™ (DE3)pLysS cells were transformed with 10ng of 
BCcalY-pET100D in a volume of 3?L using the heat shock method described 
previously and the transformed bacteria, along with untransformed bacteria (as a 
negative control) were incubated in 10mL of LB-AMP overnight at 37ºC in a 
shaking incubator.  Next, 20mL of LB-AMP was inoculated with 2mL of the 
overnight culture and was incubated under the same conditions as above for 1 
hour and 20 minutes to an OD600 of 0.7.  The cultures were then split into two 
tubes (10mL in each), one containing 1mM isopropyl ß-D thiogalactoside (IPTG), 
for induction of expression, and one without IPTG.  At each hour, 500?L of each 
culture was removed.  Once removed, the samples were centrifuged and the 
supernatant was transferred to a fresh tube, then both the supernatant and pellet 
from each culture was frozen at -20ºC for future analysis.   
 
SDS-PAGE  
 The cell pellets were resuspended in 1X SDS-Page Sample Buffer 
(Invitrogen) and the mixture was boiled for 5 minutes.  Next, 20?L of each 
sample was loaded into a 12% SDS-PAGE gel which underwent electrophoresis 
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at 200V for 45 minutes using the Mini-Protean II Electrophoresis Cell (Bio-Rad).  
After the electrophoresis was complete, the gel was stained with 0.1% 
coomassie blue R-250 (in 40% MeOH / 10%HOAc) for 30 minutes.  The gel was 
destained with several changes of 40% MeOH / 10%HOAc with a total incubation 
time of 2 hours.   
  
Western Blotting Analysis 
 Following separation by SDS-PAGE, the proteins were transferred to a 
nitrocellulose membrane using a Mini Trans-Blot® electrophoretic transfer cell 
(Bio-Rad) overnight at 30V/100mA.  Next, the membrane was placed in a 
blocking solution (TBST with 5% dry milk) for 25 minutes.  The primary antibody 
(rabbit-anticamelysin) was diluted 1:5,000 in 5mL of blocking solution and the 
membrane was incubated for 45 minutes at room temperature (14).  The 
membrane was washed three times with 20mL of TBST (TBS with 0.05% Tween 
20), 8 minute incubations were carried out for each wash.  The secondary 
antibody, anti-rabbit IgG-Alkaline phosphatase (Sigma) was diluted 1:20,000 in 
blocking buffer and the washed membrane was incubated for 45 minutes, 
followed by three more washes in TBST.  Next, the membrane was placed into 
10mL of TBS (0.1M NaCl, 0.5M Tris, pH 7.4) for rinsing  
 
Azocasein Assay 
 An azocasein assay was used to measure the proteolytic activity of the 
recombinant camelysin proteins using standard methods (30, 41).  Equal 
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volumes of the cell pellets were resuspended in 1mL of 50mM Tris-HCl, pH 7.4 
using a pipet.  After resuspension the cells were subjected to freezing and 
thawing in order to lyse the cells, alternating between a dry ice/ethanol bath and 
a 50ºC water bath.  The lysate was then subjected to sonication at 100W, 4 times 
at 20 second intervals in an ice bath.  Next, the lysate was centrifuged for 10 
minutes at 12,000 x g and 4ºC for 10 minutes.  The supernatant was removed 
and the pellets from each sample were resuspended in 400?L of 50mM Tris-HCl, 
pH 7.4. Then, 200?L of each sample were separately added to tubes containing 
200?L of the azocasein substrate solution (5mg/mL azocasein resuspended in 
50mM Tris-HCl, pH 7.4) and incubated at 37ºC for 16 hours.  The proteolytic 
activity was stopped with the addition of 800?L of 10% trichloroacetic acid (TCA), 
which also precipitates any undigested azocasein.  The samples were 
centrifuged at 12,000 x g for 4 minutes and 1mL of the supernatant was 
transferred to a cuvette.  The samples were placed in a SmartSpec Plus 
spectrophotometer (Bio-Rad) and the OD365 for each sample was recorded.   
 
Beta Galactosidase Control Assay  
 The HeLa cell pellets were washed twice with 1X PBS, pH 7.4 (Mg2+/Ca2+ 
free) and resuspended in TEN buffer (40mM Tris-HCl, pH 7.5, 1mM EDTA, pH 
8.0, and 150mM NaCl).  The cell suspension was centrifuged at 18,000 x g for 1 
minute at 4ºC, resuspended in 0.25M Tris-HCl (pH 8.0), and subjected to 3 
freeze thaw cycles by alternating between dry ice/ethanol and a 37ºC water bath.   
The lysate was then centrifuged at 18,000 x g for 2 minutes at 4ºC and the 
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supernatant was assayed.  A 96 well plate was loaded with 50?L samples from 
each transfection reaction, either diluted (1:10) or undiluted.  Next, 50?L of assay 
buffer (200mM sodium phosphate buffer, pH 7.3, 2mM MgCl2, 100mM ß-
mercaptoethanol, 1.33mg/mL ONPG) was added to each well, mixed by 
pipetting, and incubated at 37ºC for 50 minutes.  At the end of the incubation, the 
plate was visually observed for color change and 150?L of 1M sodium carbonate 
was added to each well to stop the reaction. 
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RESULTS 
 
Amplification of calY by PCR and Cloning into the pcDNA3.1/V5-His
© 
TOPO
® 
TA Expression Vector 
 Due to the fact the proteases mode of toxicity is not known, this study 
used the eukaryotic expression vector pcDNA3.1 first to examine if mammalian 
expression was possible, and secondly to observe any intracellular protease 
activity, like the lethal factor of B. anthracis.  After isolation of the genomic DNA 
from B. cereus, camelysin gene (calY) was amplified by PCR.  Primers were 
designed to amplify the 594 bp gene using the genomic DNA sequence of B. 
cereus ATCC 14579 obtained at the NCBI website, gene ID # 1203630 (Table 2).  
Due to the fact that pcDNA3.1/V5-His© TOPO® TA is a eukaryotic expression 
vector, the start codon (ATG) was incorporated into the forward primer.  This 
allowed correct translational recognition by the mammalian cells ribosome’s (17).  
This vector also has a cytomegalovirus (CMV) promoter that allows for 
overexpression of proteins once transfected into mammalian cells. Agarose gel 
electrophoresis was performed and confirmed the successful amplification of 
calY (Figure 1).  Next, calY was ligated into the pcDNA3.1/V5-His© TOPO® TA 
expression vector and was transformed into E. coli TOP10 cells.  Ligation into 
TOPO TA vectors employs the use of deoxyadenosines left on the 3? ends of 
PCR products by Taq polymerase which allowed the amplified DNA to bind to the 
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3? deoxythymidines located on the linearized vector.  The vector is kept in a 
linearized form before the insertion of amplified DNA by topoisomerase I that 
cleaves one strand of the vectors DNA after the sequence 5?-CCCTT, which is 
located at the cloning site.  The energy of this broken bond was conserved by a 
covalent bond between the 3? phosphate of the vector DNA and a tyrosyl residue 
of the topoisomerase I.  The energy was released and the bond was broken 
when the newly inserted DNA was introduced at the cloning site, which in turn 
released the topoisomerase and allowed the formation of the double stranded 
recombinant vector (Figure 2). 
 
Table 2. PCR primers used for amplification of genomic DNA and confirmation of 
gene insertion. 
 
Primer 
name 
Primer sequence DNA amplified Vector used 
pBAD 
calY 
forward 
AGTCTGAAAAAGAAATTAGGTATGG
GGAGT 
Genomic DNA from B. anthracis 
and B. cereus without the native 
GTG start codon. 
pBAD  
pcDNA 
calY 
forward 
ATGGTGAGTCTGAAAAAGAAATTAG
GTTATGGGAGT 
Genomic DNA from B. cereus 
with ATG added for mammalian 
expression system.   
pcDNA3.1 
pET calY 
forward 
CACCGTGAGTCTGAAAAAGAAATTA Genomic DNA from B. cereus 
containing CACC needed for 
insertion into vector.  
pET100/D 
pBAD 
forward 
ATGCCATAGCATTTTTATCC Vector DNA, used to confirm the 
insertion of calY.     
pBAD  
T7 forward TAATACGACTCACTATAGGG Vector DNA, used to confirm the 
insertion of calY.     
pcDNA3.1 & 
pET100/D 
Native 
calY 
reverse 
TTATTTTTCTTCCCCAGCTTCTTG Genomic DNA from B. cereus 
containing the native stop codon. 
pET100/D & 
pBAD  
pcDNA 
calY 
reverse 
TTATTTTTCTTCCCCAGCTTCTTGGT
T 
Genomic DNA from B. cereus 
containing the native stop codon.   
pcDNA3.1 
pBAD BA-
calY 
reverse 
TTATTTTTCTTCTCCAGCTTCTTG Genomic DNA from B. anthracis 
containing the native stop codon. 
pBAD  
pBAD 
reverse 
GATTTAATCTGTATCAGG Vector DNA, used to confirm the 
insertion of calY.     
pBAD  
T7 reverse TAGTTATTGCTCAGCGGTGG Vector DNA, used to confirm the 
insertion of calY.  
pET100/D 
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Figure 1. PCR amplification of the 594 bp camelysin gene (3 additional 
nucleotides for the mammalian start codon ATG) from B. cereus ATCC 14579 
using primers pcDNA calY forward and pcDNA calY reverse.  The 1% agarose 
gel confirms the presence of the 594 bp DNA fragment.  Lane 1: 100 bp ladder 
and Lane 2: amplified calY from genomic DNA.   
   
Figure 2.  Map of the mammalian expression vector pcDNA3.1/V5-His© TOPO® 
TA containing calY with the mammalian start codon ATG.  The stop codon, TAA 
was used to end translation and allowed the overexpression of the native protein 
without any fusion tags.  Ampicillin was used to screen for positive clones. 
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Confirmation of the Successful Cloning into pcDNA3.1/V5-His
© 
TOPO
® 
TA  
  Following the amplification and ligation of calY into the expression vector, 
the vector was used to transform E. coli TOP10 cells and was propagated.  
Plasmid DNA was then isolated from eight colonies and screened for correct 
insertion of calY into the vector by PCR analysis (Figure 3), restriction enzyme 
digestion with BstX I (Figure 4), and then DNA sequencing.  PCR amplification 
was carried out using 100ng of the calY-pcDNA as a template and the primers T7 
forward / pcDNA calY reverse.  The products were subjected to agarose gel 
electrophoresis and the 668 bp fragment confirmed that both the ligation into the 
vector and the insertion of calY in the correct orientation was successful.  
Restriction digestion was carried out on the recombinant plasmid and yielded two 
bands, the first representing the plasmid (6120 bp) and the second representing 
the insert with some excess vector nucleotides (638 bp), confirming the cloning 
was successful.  DNA sequencing was performed at the H. Lee Moffitt Cancer 
Center’s Molecular Biology Core Facility.  Once the sequence information was 
obtained a BLAST2seq (39) was performed against the original gene sequence 
from B. cereus ATCC 14579’s calY, confirming no mutations were introduced 
during the cloning process. 
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Figure 3.  PCR amplification products on a 1% agarose gel used for identifying 
correct insertion of calY.  Lane 1: 100 bp ladder, Lane 2: 323 bp PCR control, 
and Lanes 3-10 are recombinant plasmid amplified using the primers T7 forward 
/ pcDNA calY reverse to give the 668 bp product.  This represented a 63% 
cloning efficiency. 
 
 
 
Figure 4.  Restriction enzyme analysis on a 1% agarose gel using BstX I after 
incubation at 50ºC.   Lane 1: 100 bp ladder, Lane 2: ? Hind III ladder, Lane 3: 1hr 
incubation with BstX I, Lane 4: 1hr incubation without BstX I, Lane 5: 2hr 
incubation with BstX I, Lane 6: 2hr incubation without BstX I, Lane 7: 3hr 
incubation with BstX I, Lane 8: 3hr incubation without BstX I, Lane 9: 4hr 
incubation with BstX I, Lane 10: 4hr incubation without BstX I, Lane 11: 5hr 
incubation with BstX I, Lane 12: 5 hr incubation without BstX I.  Uncut plasmid is 
6120 bp in size, cut plasmid has two distinct bands, one 5482 bp and the other 
638 bp.   
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Transfection into HeLa cells and Expression of BCcalY-pcDNA 
 After obtaining large amounts of the recombinant plasmid using a Midi-
Prep Kit, BCcalY-pcDNA (pcDNA3.1 with the camelysin gene), calY-pcDNA (-) 
(pcDNA3.1 without any insert), and pcDNA3.1/V5-His-TOPO/lacZ© (pcDNA3.1 
that contained the ß-galactosidase control) were transiently transfected into HeLa 
cells.  The HeLa cells appeared to be confluent both before and after transfection 
in all cultures, as did a culture containing only HeLa cells that underwent the 
same lipid and medium treatments as transfected cells.  SDS-PAGE was 
performed on each of the cell cultures and no differences in banding patterns 
were observed except for the 122 kDa band present for the ß-galactosidase 
control.  Western blotting, an azocasein assay, and immunoblotting were also 
performed on each culture and all results were negative.  To test the positive 
control for ß-galactosidase activity, a ß-galactosidase assay was performed and 
demonstrated that not only did the transfection work, but it also produced the 
active ß-galactosidase protein (Figure 5). 
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Figure 5. ß-galactosidase Assay demonstrating the production of ß-
galactosidase.  Well 1 (A,B,C): pcDNA3.1/V5-His-TOPO/lacZ©, Well 2(A,B,C): 
pcDNA3.1/V5-His-TOPO/lacZ© diluted 1:10, Well 3(A,B,C): calY-pcDNA (-), Well 
4(A,B,C): calY-pcDNA (-) diluted 1:10, Well 5(A,B,C): BCcalY-pcDNA, Well 
6(A,B,C): BCcalY-pcDNA diluted 1:10, Well 7(A,B,C): HeLa cells, Well 8(A,B,C): 
HeLa cells diluted 1:10. 
 
   
Amplification of calY by PCR and Cloning into the pBAD TOPO
®
 TA 
Expression Vector 
 Genomic DNA containing the camelysin gene from both B. anthracis and 
B. cereus was amplified by PCR using the Expand Long Template PCR system 
for insertion into the pBAD TOPO® TA vector (Figure 6) to examine if prokaryotic 
expression was possible without the generation of a fusio tagged protein.  This 
system contains a mixture of two polymerases (Taq and Tgo) that gave a high 
yield of PCR product that was proofread via the Tgo polymerases 3’-5’ 
exonuclease activity.  The pBAD vector is advantageous for use in expressing 
suspected toxic proteins as it contains the tightly regulated araBAD promoter, 
which controls the level of protein expression.  Another advantage to using this 
vector system is the fact that it contains a short N-terminal leader peptide, which 
improved translation of the protein and also increased its solubility (42). The 
vector also allows a V-5 epitope and a polyhistidine tag to be placed at the C-
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terminal end of a recombinant protein, which could prove useful for detecting a 
fusion protein.  However, in this experiment the tags were left out since we 
already had the antibody for purified camelysin and the tags cannot be cleaved 
off once placed onto the native protein.  The genomic DNA sequence for the B. 
anthracis camelysin gene was obtained from the NCBI website (39), protein ID # 
AAP25246.1.  The start codon was removed from the forward primer since the 
vector contains its own initiation codon, and the stop codon was left to prevent 
formation of a fusion tagged protein.  The PCR product was obtained and then 
ligated into the TA vector as previously described (Figure 7).  Following ligation, 
E. coli TOP10 cells were transformed with the recombinant vector and grown in 
LB-AMP to propagate the plasmid.   
 
 
 
Figure 6. PCR amplification of calY from B. anthracis using primers pBAD calY 
forward / pBAD BA-calY reverse and from B. cereus using primers pBAD calY 
forward / Native calY reverse for cloning into pBAD TOPO® TA.  The 1% gel 
confirms the presence of the 591 bp camelysin gene (no start codon on primer).  
Lane 1: 1kb ladder, Lanes 2-3: B. anthracis calY, and Lanes 4-5: B. cereus calY.   
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Figure 7.  Map of the prokaryotic expression vector pBAD TOPO® TA containing 
calY without its own start codon, GTG.  The stop codon, TAA was used to end 
translation to allow expression of the native protein without any fusion tags.  
Ampicillin was used to screen for positive clones once transformed into E. coli 
TOP10 cells. 
   
 
Confirmation of the Successful Cloning into pBAD TOPO
®
 TA 
 The products obtained by PCR amplification of calY from B. anthracis and 
B. cereus were ligated into the pBAD vector and used to transform TOP10 cells, 
recombinant plasmid was then isolated from five colonies using Mini-Preps.  The 
recombinant plasmid was then screened for correct insertion of calY into the 
vector by PCR analysis (Figures 8Aand 8B), and DNA sequencing.  PCR 
amplification was carried out using approximately 100ng of BAcalY-pBAD and 
BCcalY-pBAD as templates and the primers for both the camelysin gene and the 
vector.  The products were subjected to agarose gel electrophoresis and the 
distinct bands at 594 bp and 773 bp confirmed that both the ligation into the 
vector and the insertion of calY in the correct orientation were successful. 
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Figure 8A.  PCR amplification products on a 1% agarose gel used for identifying 
the correct insertion of BAcalY and BCcalY into the pBAD vector.  Lane 1: 1kb 
ladder, Lanes 2-6: PCR of BAcalY using pBAD calY forward / pBAD BA-calY 
reverse, Lane 7: Empty well, and Lanes 8-12: PCR of BAcalY using pBAD 
forward / pBAD BA-calY reverse.  This represented a 60% cloning efficiency. 
 
 
Figure 8B.  PCR amplification products on a 1% agarose gel used for identifying 
the correct insertion of BAcalY and BCcalY into the pBAD vector.  Lane 1: 1kb 
ladder, Lanes 2-6: PCR of BCcalY using pBAD calY forward / Native calY 
reverse, Lane 7: 1kb ladder, Lane 8: Empty well, and Lanes 9-13: PCR of 
BCcalY using pBAD forward / Native calY reverse.  This represented a 40% 
cloning efficiency. 
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DNA sequencing was performed at SeqWright DNA Technologies 
(Houston, TX).  Once the sequence information was obtained a BLAST2seq (39) 
was performed against the original gene sequences from both B. anthracis and 
B. cereus ATCC 14579’s calY, confirming no mutations were introduced during 
the cloning process. 
 
Expression of BAcalY-pBAD and BCcalY-pBAD 
 Expression of BAcalY-pBAD and BCcalY-pBAD was induced in E. coli 
TOP10 cells by using different concentrations of arabinose to identify the amount 
needed for successful expression of the protease.  The induced culture was 
incubated at 30ºC in a shaking incubator for 4 hours.  At the end of the 4 hours, 
the OD600 was recorded for each culture and the averages were 2.4 for BAcalY-
pBAD, 2.2 for BCcalY-pBAD, and 3.1 for E. coli TOP10 with no vector. The lower 
values for BAcalY-pBAD and BCcalY-pBAD indicate the possible  presence of 
toxicity in the cells expressing camelysin.  SDS-PAGE was performed on each of 
the samples and the 19 kDa mature camelysin protein was observed for both the 
B. anthracis and B. cereus constructs (Figures 9 and 10 respectively).  The 
greatest amount of protein seemed to be produced when each induced sample 
had arabinose at a final concentration of 0.002%. 
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Figure 9.  Expression of calY from BAcalY-pBAD construct.  Lane 1: MW marker, 
Lane 2: uninduced BAcalY-pBAD, Lanes 3-7: BAcalY-pBAD induced with 0.2%, 
0.02%, 0.002%, 0.0002%, and 0.00002% arabinose respectively, Lane 8: pBAD 
vector with no insert induced with 0.2% arabinose, and Lane 9: E. coli TOP10 
cells with no vector induced with 0.2% arabinose.  The camelysin protein (~19 
kDa) can be seen in lanes 3-7, however the strongest bands are in lanes 5 and 
6.   
 
Figure 10. Expression of calY from BCcalY-pBAD construct.  Expression of calY 
from BCcalY-pBAD construct.  Lane 1: MW marker, Lane 2: empty well, Lane 3: 
uninduced BCcalY-pBAD, Lanes 4-8: BCcalY-pBAD induced with 0.2%, 0.02%, 
0.002%, 0.0002%, and 0.00002% arabinose respectively, Lane 9: pBAD vector 
with no insert induced with 0.2% arabinose, and Lane 10: E. coli TOP10 cells 
with no vector induced with 0.2% arabinose.  The camelysin protein (~19 kDa) 
can be seen in lanes 4-8, however the strongest bands are in lanes 6 and 7.   
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Amplification of calY by PCR and Cloning into the pET100/D-TOPO
®
 
Expression Vector 
 DNA from B. cereus ATCC 14579 was amplified by PCR using the 
PfuTurbo
® DNA polymerase for integration into pET100/D-TOPO® (Figure 11) to 
examine if the creation of a fusion tagged protein would effect expression levels 
of camelysin.  The Pfu polymerase contains 3’-5’ exonuclease activity much like 
the Tgo polymerase used for cloning into the pBAD system.  However, the Pfu 
polymerase does not add any deoxyadenosines onto the PCR product because it 
lacks this activity, which leaves the PCR products with blunt ends.  Ligation of the 
PCR product into this TOPO vector required the sequence CACC to be added 
onto the forward primer of camelysin.  The linearized vector contains a region 
complimentary to this sequence, thus allowing directional binding of the PCR 
product to the vector that is also in frame with the other genes on the vector.  
Primers were designed with the CACC located in the forward primer (pcDNA 
calY forward) without a stop codon following the sequence that allowed 
expression of a fusion protein containing the N-terminal polyhistidine tag and 
X™press epitope, while the reverse primer (Native calY reverse) contained 
camelysin’s native stop codon (Figure 12).  Once the PCR product was obtained, 
it was ligated into the vector and transformed into E. coli TOP10 cells for 
propagation.   
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Figure 11.  PCR amplification of the 598 bp camelysin gene (4 additional 
nucleotides for the addition of CACC) from B. cereus ATCC 14579.  The 1% 
agarose gel confirms the presence of the 598 bp DNA fragment.  Lane 1: 1kb 
plus ladder and Lane 2: amplified calY from genomic DNA.   
 
 
Figure 12.  Map of the prokaryotic expression vector pET100/D-TOPO® 
containing the native calY with the addition of CACC at the 5? end.  The stop 
codon, TAA was used to end translation and ampicillin was used to screen for 
positive clones once transformed into E. coli TOP10 cells.   
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Confirmation of the Successful Cloning into pET100/D-TOPO
® 
 Plasmid DNA from five E. coli clones were obtained and screened for the 
presence of the camelysin gene using PCR (Figures 13A and 13B) and DNA 
sequencing.  The plasmid DNA containing the camelysin gene was PCR 
amplified using the primers sets T7 forward / Native calY reverse and pET calY 
forward / T7 reverse yielding fragments of 794 bp and 679 bp respectively, 
confirming that camelysin was inserted into the vector. 
 
                  
Figure 13A.  PCR amplification products on a 1% agarose gel used for identifying 
the correct insertion of BCcalY into the pET vector.  Lane 1: 1kb plus ladder and 
Lanes 2-6: PCR of BCcalY-pET100D using T7 forward / Native calY reverse.  
This represented a 20% cloning efficiency. 
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Figure 13B.  PCR amplification products on a 1% agarose gel used for identifying 
the correct insertion of BCcalY into the pET vector. Lane 1: 1kb, plus ladder and 
Lanes 2-6: PCR of BCcalY-pET100D using pET calY forward / T7 reverse. 
 
 
DNA sequencing on BCcalY-pET100D was performed at SeqWright DNA 
Technologies (Houston, TX).  Once the sequence information was obtained a 
BLAST2seq (39) was performed against the original gene sequences from B. 
cereus ATCC 14579’s calY, confirming no mutations were introduced during the 
cloning process and that the gene was inserted into the TOPO vector.  The 
vector was then transformed into E. coli BL21 Star™ (DE3)pLysS for expression.   
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Expression of BCcalY-pET100D 
The vector contains a T7lac promoter that was induced by production of 
T7 RNA polymerase in the host cells and a lac operator that the lacI repressor 
protein (expressed in the BL21 cells) binds, thus decreasing the chances of basal 
expression.  E. coli BL21 Star™ (DE3)pLysS cells have the lambda DE3 lysogen 
which has the gene for the T7 RNA polymerase and is tightly regulated by the 
lacUV5 promoter in the cells chromosome.  IPTG was used to turn on the lacUV5 
promoter, which resulted in overexpression of the protein encoded by the PCR 
product that was inserted into the pET vectors cloning site.  Since 
overexpression can be a problem with toxic proteins, the BL21 Star™ 
(DE3)pLysS strain were used to express camelysin since they also produce a T7 
lysozyme that slowed expression by binding to T7 RNA polymerase and 
inactivating it.  The BL21 cells transformed with BCcalY-pET100D were induced 
with IPTG for 4 hours.  After each hour, samples were taken and stored for 
further analysis.  SDS-PAGE was performed on the all of the samples (Figure 
14), and no noticeable differences were apparent upon staining with Coomassie 
blue. 
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Figure 14.  Expression of BCcalY-pET100D in BL21 Star™ (DE3)pLysS cells. No 
banding pattern differences were discernable.   
Lanes 1 & 11: MW marker, Lane 2: Induced BL21 Star™ (DE3)pLysS cells, 
Lanes 3, 5, 7, & 9: Uninduced BL21 cells at 1, 2, 3, and 4 hours respectively, 
Lanes 4, 6, 8, & 10: Induced BL21 cells at 1, 2, 3, and 4 hours respectively. 
 
 
Western Blotting Analysis 
 After performing SDS-PAGE on samples from each vector system, a 
Western blot was performed and confirmed that the protein bands that were 
apparent on some of the gels were indeed that of camelysin (Figure 15).  Despite 
not seeing any noticeable bands on the SDS-PAGE performed on the BCcalY-
pET100D expression, two bands were apparent in the samples that were 
induced with IPTG for 3 hr and 4 hr.  These bands were located around 65 kDa 
and the purple color is indicative of a positive reaction, while the brown colored 
bands are negative.  The 19 kDa bands seen on the SDS-PAGE from the 
BAcalY-pBAD and BCcalY-pBAD expression were apparent on the Western blot 
at the same location, thus indicating successful expression in both the pET and 
pBAD vector systems.   
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Figure 15.  Western blotting analysis of camelysin expressed in the pBAD and 
pET vector systems.  Lane 1: BCcalY-pET100D after 3 hr induction, Lane 2: 
BCcalY-pET100D after 4hr induction, Lane 3: BAcalY-pBAD induced with 
0.002% arabinose, and Lane 4: BCcalY-pBAD induced with 0.002% arabinose. 
 
 
Azocasein Assay 
 To test the proteolytic activity present in all three vector system expression 
experiments, an enzyme assay using azocasein as a substrate was performed.  
Azocasein is made up of orange sulfanilamide groups that are covalently bound 
to the peptide bonds of casein.  Once a protease attacks these bonds, small 
peptides and sometimes amino acids are released giving the solution a dark 
orange color.  TCA was added after an overnight incubation at 37ºC, which 
precipitated the protease and any undigested azocasein.  Following 
centrifugation, the small digested particles (giving the orange color) are 
contained in the supernatant and the OD365 is read (Figure 16), thus the higher 
the OD, the greater the amount of proteolytic activity present.  The supernatants 
 42
of BAcalY-pBAD, BCcalY-pBAD, and BCcalY-pET100D appear to have the 
highest proteolytic activity indicating the presence of camelysin.  The pellets also 
contain some activity, but less than the supernatants.  Negative controls included 
HeLa cells transfected with the pcDNA vector with no insert (calY-pcDNA(-)) and 
E. coli TOP10 cells transformed with the pBAD vector with no insert. 
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Figure 16.  Degradation of azocasein by camelysin.  An increase in the OD365 
indicated high proteolytic activity in the supernatants of the cells that were 
transformed and induced with camelysin using either the pBAD or pET vectors.  
Top10 cells transformed with the empty pBAD vector appear to have some 
proteolytic activity, but is insignificant when compared to the Top10 cells that 
were transformed with either BAcalY-pBAD, BCcalY-pBAD, or BCcalY-pET100D.  
HeLa cells transfected with the empty pcDNA vector exhibited minute levels of 
proteolytic activity.  Error bars indicate the standard deviation from the mean for 
each cell type used.   
 
 
Sequence Analysis of calY in B. anthracis and B. cereus ATCC 14579 
 A multiple sequence alignment was performed on both the nucleotide 
(Figure 18) and amino acid (Figure 17) sequences of calY from B. anthracis and 
B. cereus using the GAP alignment tool from the GCG Wisconsin Package® 
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software to check for the degree of homology between the two proteins and their 
genes.  The results of the alignment concluded there is a 94.78% similarity 
between the two organism’s nucleotide sequences.  Out of the 594 nucleotides in 
both camelysin genes, there were 30 differences between the two sequences 
(Figure 18).  There are 197 amino acids in both camelysin genes; the alignment 
identified 9 amino acid differences between the two sequences and concluded 
there was a 95.94% similarity between the two amino acid sequences (Figure 
17).   
 
Figure 17. Multiple sequence alignment of the amino acid residues for camelysin 
from B. anthracis and B. cereus.  The first amino acid sequence is that of B. 
anthracis and the second is that of B. cereus.  The amino acids that are 
highlighted in gray indicate a difference between the two proteins.  Two dots 
between each residue that differs indicates a threshold of 2 for the alignment 
score conveying a strong similarity between the two amino acids, and one dot 
between each residue indicates a threshold of 1 for the alignment, conveying a 
similarity between the two amino acids, but not as high.  A blank space between 
the residues indicates no similarity between the different amino acid residues.   
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Figure 18.  Multiple sequence alignment of the nucleotides for camelysin from B. 
anthracis and B. cereus.  The first nucleotide sequence is that of B. anthracis and 
the second is that of B. cereus.  The nucleotides that are highlighted in gray 
indicate a difference between the two genes.   
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Prediction of the Putative Signal Peptide of Camelysin from B. anthracis 
and B. cereus ATCC 14579 using Neural Network and Hidden Markov 
Models.   
 Both neural network and hidden Markov models were used to predict 
where the putative signal peptide of the camelysin protein is located using the 
SignalP 3.0 server (3).  Due to the fact this protease exhibits unusual behavior 
and has no conserved domains it was imperative to perform several forms of 
sequence analysis.  The signal peptide analysis allows us to view differences 
between the two proteins signal peptides as well as differences in their cleavage 
sites.  The neural network model calculates where both the predicted signal 
peptide and the position of the signal peptidase I cleavage site are located using 
two separate networks.  The signal peptide was predicted to contain amino acids 
1-29 with a cleavage site between residues 29 and 30 for the camelysin protein 
of B. anthracis and B. cereus ATCC 14579 (Figures 19A and 19B).   
 The hidden Markov model calculates whether or not a given amino acid 
sequence contains a signal peptide.  If the sequence of interest is predicted to 
contain a signal peptide the location of the cleavage site, N-terminus, C-terminus, 
and alpha-helical segments of the signal peptide are included in the output.   The 
Markov model predicted the signal peptide to consist of amino acid residues 1-27 
with a cleavage site between residues 27 and 28 for the camelysin protein of B. 
 46
anthracis and B. cereus ATCC 14579 (Figures 20A and 20B).  The N-terminal 
region of the signal peptide was predicted to be comprised of residues 1-6, the 
alpha helical region 7-20, and the C-terminal region to be from 21-27 in the 
protease from both organisms.   
 
 
Figures 19A and 19B.  SignalP 3.0’s neural network model prediction of the 
camelysin protein’s signal peptide.  The C score corresponds to the probability 
that a particular residue is located at the signal peptidase I site, the S score 
reflects the probability that residues are part of the signal peptide, and the Y 
score helps to predict the cleavage site at points where the steep slopes of the C 
score line are located.  Figure A is the sequence from B. anthracis and Figure B 
is the sequence from B. cereus.  Camelysin from both organisms are predicted to 
contain the same signal peptide and are predicted to be secreted.   
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Figures 20A and 20B.  SignalP 3.0’s hidden Markov model prediction of the 
camelysin protein’s signal peptide.  The cleavage probability is the location 
where cleavage of the signal peptide is most likely to occur; the N-region, H-
region, and C-region probabilities correspond to the predicted N-terminal, alpha 
helical, and C-terminal regions of the signal peptide.  Figure A is the sequence 
from B. anthracis and Figure B is the sequence from B. cereus.  Camelysin from 
both organisms are predicted to contain the same signal peptide and are 
predicted to be secreted.   
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Secondary Structure Prediction of Camelysin from B. anthracis and B. 
cereus ATCC 14570 
 The predicted secondary structure of camelysin was obtained from the 
PSIPRED Protein Structure Prediction Server (21, 28).  A multiple sequence 
alignment was performed using the GAP alignment tool from the GCG Wisconsin 
Package® software to identify similar structural characteristics between the two 
peptides from B. anthracis and B. cereus ATCC 14579 (Figure 21).  The 
alignment revealed that the secondary structure between the two proteins is 
95.94% similar.  The alpha helical region of the predicted signal peptide is also 
apparent in this secondary structure analysis, however there are also two other 
helical regions, possibly involved with anchoring the protein to the membrane of 
the cell (Figures 22 and 23).   
 
Figure 21.  Secondary structure comparison between camelysin from B. cereus 
and B. anthracis.  Out of the 197 peptides, only 4 peptides exhibited different 
secondary structure characteristics between the two peptide strands (gray 
residues).  C, E, and H correspond to coil, strand, and helix respectively. 
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Figure 22.  Secondary structure prediction of camelysin from B. anthracis using 
PSIPRED.  The protein is predicted to contain 4 alpha helices and 12 strands.   
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Figure 23.  Secondary structure prediction of camelysin from B. cereus using 
PSIPRED.  The protein is predicted to contain 4 alpha helices and 12 strands, 
identical to the prediction for the proteins secondary structural characteristics for 
B. anthracis.   
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DISCUSSION 
The focus of this study was aimed at identifying, cloning, and expressing 
the active camelysin protease from B. cereus ATCC 14579 and B. anthracis.  
Previous studies demonstrated that camelysin isolated from an uncharacterized, 
unsequenced strain of B. cereus may play a role in the pathogenicity of this 
organism, which is why B. cereus ATCC 14579 was chosen.  Blastn and blastp 
searches revealed a putative camelysin gene may also be located in B. 
anthracis.  These findings along with the fact that B. anthracis is such a potent 
pathogen were the reasons why it was chosen for this study.  Identifying a 
suitable method for obtaining large amounts of this highly hydrophobic 
membrane protease was another goal of this project due to the difficulty in 
obtaining even minute amounts of the protease from the native organism and 
also due to the dangers of culturing live B. anthracis.  Obtaining large amounts of 
the camelysin protease, with or without a fusion tag will allow future studies to be 
performed that are focused on the delineation of camelysin’s possible role in the 
pathogenicity of these organisms.   
The camelysin gene from B. cereus ATCC 14579 was first cloned into the 
mammalian expression vector pcDNA3.1/V5-His© TOPO® TA.  Several proteins 
are linked to pathogenicity by causing damage intracellularly, like the lethal factor 
of B. anthracis.  A mammalian expression vector was used to see if it would be 
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possible to express the protease intracellularly in a mammalian cell line to 
observe any possible pathogenic effects of the enzyme.  This would allow 
intracellular studies of camelysin’s involvement in pathogenicity without 
purification of the protease, reconstitution into liposome’s, and then adding the 
protein to a cell culture.  PCR, restriction digestion analysis, and DNA 
sequencing confirmed that BCcalY was successfully inserted into the vector.  
Plasmid was obtained by performing large scale plasmid isolation from the 
transformed TOP10 cells and the DNA electrophoresis confirmed the purity of the 
recombinant plasmid.  HeLa cells were grown to confluency and the recombinant 
vector was transiently transfected into the cells.  Unfortunately there was no 
expression of the camelysin protein as indicated by SDS-PAGE, western blotting, 
immunoblotting analysis, and an azocasein assay.  To make sure there were no 
errors with the transfection, the positive control pcDNA3.1/V5-His-TOPO/lacZ© 
(pcDNA3.1 that contained the ß-galactosidase control) was transfected into the 
same HeLa cell cultures during the expression experiment.  The IPTG assay 
(Figure 5) demonstrated that there was ß-galactosidase activity, indicating there 
were no problems with the transfection methodology.   
There are several possible explanations for the mammalian expression 
failure.  Mammalian systems often do not process or fold heterologous proteins 
properly because of different translational and post-translational machinery.  The 
mature camelysin protein exhibits self aggregation and is extremely hydrophobic 
most probably due to oligomerization (13).  These characteristics are only 
exhibited in the properly folded protein; if camelysin is not properly folded it could 
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be recognized by intracellular proteases which would destroy any camelysin 
protein produced immediately after translation.  In addition, bacterial membrane 
proteases often need specific bacterial transport systems, like the Sec pathway 
for crossing and integrating into the membrane of the cells; in HeLa cells these 
pathways are not present.  HeLa cell membranes also contain a much different 
phospholipid environment than the ones found in prokaryotic cell membranes.  
Direct membrane insertion of membrane bound proteases is often based on 
phospholipid composition (15).   
Following the expression trial in the mammalian system, the camelysin 
gene was cloned into the pET100/D-TOPO®, vector.  The pET vector has several 
advantages over pcDNA3.1/V5-His© TOPO® TA.  There are two N-terminal fusion 
tags, a histidine tag and an X™press epitope which can be used for purification 
or detection of a fusion protein and both can be removed using enterokinase, due 
to the presence of an enterokinase cleave site located C-terminal to the tags.  
After successful PCR amplification the gene was inserted into the vector and 
transformed into the TOP10 cells.  PCR and DNA sequencing confirmed that 
BCcalY was successfully inserted into the vector.   
Mini-preps were performed on the TOP10 cells and the vector was 
transformed into E. coli BL21 Star™ (DE3)pLysS cells.  Once induced with IPTG, 
the cells expressed the recombinant protease in a controlled manner.  SDS-
PAGE was unable to demonstrate the successful expression of camelysin once 
stained with coomassie blue.  This is not unusual since previous studies have 
shown (13) that camelysin in its mature state forms hydrophobic aggregates that 
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do not stain with coomassie blue.  However, western blot analysis detected a 
positive result with band at 65 kDa, similar to the molecular weight obtained of 
aggregated camelysin on SDS-PAGE gels that were stained with colloidal gold in 
previous studies (15).  In addition to the positive results obtained for the western 
blot, the protein also exhibited proteolytic activity using an azocasein assay 
(Figure 16), indicative of the presence of camelysin in its active form.   
Next, the camelysin gene from B. anthracis and B. cereus was cloned into 
the pBAD TOPO® TA expression vector.  The camelysin gene from B. anthracis 
was only cloned into this vector due to the difficulty in obtaining the genomic 
DNA.  This allowed us to examine the expression of camelysin from both 
organisms using an expression vector designed especially for producing toxic 
proteins.  Additionally, this vector contains an N-terminal leader peptide that is 
shown to increase the solubility of recombinant proteins.  The C-terminal histidine 
tag and V-5 epitope were purposely left out of the recombinant protein since they 
can not be removed from the protein after purification, and their effects on the 
enzymatic activity were not known at the time.  Once inserted into the vector, it 
was transformed into TOP10 cells and confirmation of the genes correct 
orientation and sequence was accomplished by PCR and DNA sequencing.   
The recombinant clones expressed camelysin after induction using 
various concentrations of arabinose.  SDS-PAGE confirmed the expression of 
the mature, non-aggregated 19 kDa protease after staining with coomassie blue.  
There are many possible explanations for the difference in molecular weight 
between expressions, the first being the presence of fusion tags on the protease 
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of the pET vectors product.  By adding the tags, the protease may have taken on 
a more native and aggregated form as seen in previous studies, which does not 
stain well when coomassie blue is used.  The hydrophobic aggregation of this 
protease makes it difficult for it to travel through SDS-PAGE gels even after using 
reducing conditions (13).  The proteins expressed in the pBAD system, lacked 
these fusion tags and also contained a leader peptide which increases the 
solubility of most the proteins that are expressed, which would explain the 
different results on SDS-PAGE between the pBAD and pET systems.  A western 
blot performed on both the BAcalY-pBAD and BCcalY-pBAD recombinant 
proteins demonstrated a positive result which included a band at 19 kDa, backing 
up the SDS-PAGE analysis.  An azocasein assay was performed on the two 
recombinant proteins following the western blot, and both demonstrated 
proteolytic activity, consistent with the active native protease obtained from B. 
cereus and the pET vectors recombinant protease.   
Various methods of sequence analysis were performed on the camelysin 
gene and protein from both B. cereus ATCC 14579 and B. anthracis Ames strain.  
The first analysis included a multiple sequence alignment which demonstrated 
the high similarity between the two sequences at both the nucleotide and amino 
acid level.  Since camelysin from B. cereus is shown to have properties 
suggesting it may be involved in pathogenesis, it gave reason to clone the gene 
from both organisms.  Signal peptide analysis using SignalP 3.0 allowed 
prediction of the position of the signal peptide, its cleavage site, and whether or 
not the peptide is soluble or insoluble.  The mature protein was show to have 2 
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different predicted sites of cleavage, probably due to the different models used, 
the first site was between amino acid residues 29 and 30 and the other was 
between amino acids 27 and 28, the latter was previously reported as the 
putative site in another paper (16).   
Secondary structure analysis was performed using PSIPRED.  Results of 
the structure analysis further strengthened the possibility that the signal peptide 
of camelysin was located within the first 30 amino acids.  Previous studies on 
camelysin suggest this location due to the fact that signal peptides usually have 
basic amino acids in the N-terminus, followed by a hydrophobic section of amino 
acids (usually represented by helical secondary structures), and Gly residues at 
the C-terminus (16, 25, 30, 33).   The PSIPRED prediction found two more 
possible alpha helices not previously described that could be involved in with the 
hydrophobic interactions that keep camelysin associated to the cell membrane.  
Grass, et al, have already demonstrated that camelysin is neither bound to the 
cell membrane by electrostatic interactions (camelysin was not removed from cell 
membrane after washing under high salt conditions and after using enzymes that 
cause lysis), transmembrane stretches of hydrophobic amino acids (which is only 
found in the N-terminal signal peptide), the modifications of lipoproteins (the 
recognition domain for the lipoprotein signal peptidase is not present in 
camelysin), or covalent linkages (molecular mass of protein matches well with 
predicted molecular mass from sequence) (16).  The two new alpha helices 
seem to exhibit amphipathic properties (data not shown) from a hydrophobicity 
prediction performed in the Clone Manager software (Science and Educational 
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Software, Inc. Cary, NC.).  These amphipathic alpha helices are one possible 
way that the protease may bind to the cell membrane and they fall within one of 
the six hydrophobic domains found using the DAS transmembrane server (8) 
identified in previous studies (Grass 2004).    
This study indeed proves that the camelysin gene is found both in B. 
cereus and B. anthracis, and that the active protease, although only weakly 
proteolytic, can be expressed in gram negative prokaryotic expression systems.  
This will prove extremely useful in the future as this system, or newer gram 
positive vector systems can be used to create knock-out clones to identify the 
active region of the camelysin protein (9).  Due to the fact that camelysin was 
found in B. anthracis and B. cereus and since previous studies demonstrate it 
contains pathogenic activity, some of the recombinant clones used in this study 
can be useful for large scale preparation of camelysin for cell culture and 
possibly animal models to examine the role it may have in the pathogenicity of 
these organisms.   
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